Skip to Main Content
Table 2.

Patient characteristics and repeat tumor PET 2-[11C]thymidine parameter data

PtPrimary siteImaged siteAge (y)PSInjected activity
SUVend
AUC0-1 hour
FRT
1st2nd1st2nd1st2nd1st2nd
Cholangiocarcinoma Liver 39 323 135 2.61 2.15 205 205 0.287 0.304 
Colorectal Liver 61 383 274 1.37 1.56 131 130 0.189 0.152 
Stomach Lung 71 375 272 1.05 1.10 85 84 0.390 0.372 
Colorectal Liver 60 557 534 2.27 2.00 100 110 0.204 0.193 
Colorectal Liver 76 388 265 3.70 3.43 120 120 0.372 — 
Pancreas Pancreas 68 481 373 1.45 1.23 167 158 0.204 0.193 
Pancreas Pancreas 53 413 475 1.49 1.55 247 250 0.149 0.195 
PtPrimary siteImaged siteAge (y)PSInjected activity
SUVend
AUC0-1 hour
FRT
1st2nd1st2nd1st2nd1st2nd
Cholangiocarcinoma Liver 39 323 135 2.61 2.15 205 205 0.287 0.304 
Colorectal Liver 61 383 274 1.37 1.56 131 130 0.189 0.152 
Stomach Lung 71 375 272 1.05 1.10 85 84 0.390 0.372 
Colorectal Liver 60 557 534 2.27 2.00 100 110 0.204 0.193 
Colorectal Liver 76 388 265 3.70 3.43 120 120 0.372 — 
Pancreas Pancreas 68 481 373 1.45 1.23 167 158 0.204 0.193 
Pancreas Pancreas 53 413 475 1.49 1.55 247 250 0.149 0.195 

NOTE: Injected activity is expressed in MBq. SUVend in g/mL is calculated as the average value between 3,000 and 3,600 seconds. AUC0-1 hour is expressed in g-h/mL. A second FRT measurement was not obtained in one patient because of an inadequate input function.

Abbreviations: Pt, patient number; PS, WHO performance status.

Close Modal

or Create an Account

Close Modal
Close Modal